Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity
 
research article

Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity

Borcard, Francoise  
•
Baud, Matthias
•
Bello, Claudia
Show more
2010
Bioorganic & Medicinal Chemistry Letters

New oxathiazinane dioxides have been derived from D- and L-serine and tested for their in vitro cell growth inhibitory activity toward SKBR3 breast cancer cells. (5R)-5-(4-(4'-Bromomethyl)phenyl)benzyloxymethyl-[1,3,4]-oxathiazinane- 3,3-dioxide showed a cytotoxicity of IC50 approximate to 10 mu M. (C) 2009 Elsevier Ltd. All rights reserved.

  • Details
  • Metrics
Type
research article
DOI
10.1016/j.bmcl.2009.09.019
Web of Science ID

WOS:000281247000081

Author(s)
Borcard, Francoise  
Baud, Matthias
Bello, Claudia
Dal Bello, Giovanna
Grossi, Francesco
Pronzato, Paolo
Cea, Michele
Nencioni, Alessio
Vogel, Pierre  
Date Issued

2010

Published in
Bioorganic & Medicinal Chemistry Letters
Volume

20

Start page

5353

End page

5356

Subjects

Benzyl ethers

•

Cancer

•

Cytotoxicity

•

Oxasultams

•

Sultams

•

Et-18-Och3 Edelfosine

•

Tumor-Cells

•

Jaspine-B

•

Apoptosis

•

Design

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LGSA  
Available on Infoscience
December 16, 2011
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/75248
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés